You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GALT Exercise Disclosure
Uihlein Richard E · SEC Form 4 · Filed Aug 4, 2026
Exercise
Reported value range
Not reported
Uihlein Richard E Director / Ten Percent Owner
GALT
Transaction date
Jul 31, 2026
Public filing date
Aug 4, 2026
Filing lag
Filed 4 days later
GALT daily price context
Close on/before transaction
$2.97
Jul 31, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Line of Credit Convertible Notes on Common Stock
- Quantity / price
- Derivative security
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001133416-26-000065
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$105.81M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Galectin Therapeutics Inc GALT | Exercise | Jul 31, 2026 | $95.48M |
| Galectin Therapeutics Inc GALT | Exercise | Jul 31, 2026 | $10.33M |
| Galectin Therapeutics Inc GALT Current | Exercise | Jul 31, 2026 | Not reported |
| Galectin Therapeutics Inc GALT | Exercise | Jul 31, 2026 | Not reported |